{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:52:20Z","timestamp":1785340340813,"version":"3.55.0"},"reference-count":27,"publisher":"Europa Digital & Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.4244\/eijy14m06_07","type":"journal-article","created":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T06:24:42Z","timestamp":1441520682000},"page":"381-390","source":"Crossref","is-referenced-by-count":46,"title":["Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial"],"prefix":"10.4244","volume":"11","author":[{"given":"Willem J. M.","family":"Dewilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek W.A.","family":"Verheugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.G.L.","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Adriaenssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus B.","family":"Brueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoff","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline J.","family":"Breet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-20159611030-0","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1160\/TH09-08-0580","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary intervention\/stenting.","volume":"103","author":"Lip GY.","year":"2010","journal-title":"Thromb Haemost."},{"key":"key-20159611030-1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.","volume":"170","author":"Hansen ML.","year":"2010","journal-title":"Arch Intern Med."},{"key":"key-20159611030-2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ahj.2009.09.001","article-title":"Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).","volume":"158","author":"Dewilde W.","year":"2009","journal-title":"Am Heart J."},{"key":"key-20159611030-3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.","volume":"381","author":"Dewilde WJ.","year":"2013","journal-title":"Lancet."},{"key":"key-20159611030-4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis In Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.","volume":"76","author":"Chesebro JH.","year":"1987","journal-title":"Circulation."},{"key":"key-20159611030-5","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran R.","year":"2011","journal-title":"Circulation."},{"key":"key-20159611030-6","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-20159611030-7","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction.","volume":"116","author":"Thygesen K.","year":"2007","journal-title":"Circulation."},{"key":"key-20159611030-8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1253\/circj.CJ-11-1206","article-title":"Heparin bridging vs. uninterrupted oral anticoagulation in patients with atrial fibrillation undergoing coronary artery stenting. Results from the AFCAS registry.","volume":"76","author":"Lahtela H.","year":"2012","journal-title":"Circ J."},{"key":"key-20159611030-9","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/01.CIR.103.16.2042","article-title":"Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.","volume":"103","author":"ten Berg JM.","year":"2001","journal-title":"Circulation."},{"key":"key-20159611030-10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/eurheartj\/ehn099","article-title":"Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.","volume":"29","author":"Karjalainen PP.","year":"2008","journal-title":"Eur Heart J."},{"key":"key-20159611030-11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ccd.21758","article-title":"Percutaneous coronary intervention in anticoagulated patients via radial artery access.","volume":"73","author":"Helft G.","year":"2009","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20159611030-12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ccd.10595","article-title":"Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.","volume":"60","author":"Jessup DB.","year":"2003","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20159611030-13","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.107.727784","article-title":"Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.","volume":"116","author":"Wazni OM.","year":"2007","journal-title":"Circulation."},{"key":"key-20159611030-14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.amjcard.2008.04.003","article-title":"Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment.","volume":"102","author":"Annala AP.","year":"2008","journal-title":"Am J Cardiol."},{"key":"key-20159611030-15","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation.","volume":"368","author":"Birnie DH.","year":"2013","journal-title":"N Engl J Med."},{"key":"key-20159611030-16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ahj.2007.09.003","article-title":"Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.","volume":"155","author":"Wang TY.","year":"2008","journal-title":"Am Heart J."},{"key":"key-20159611030-17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.amjcard.2005.09.079","article-title":"Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation.","volume":"97","author":"El-Jack SS.","year":"2006","journal-title":"Am J Cardiol."},{"key":"key-20159611030-18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0002-8703(98)70223-6","article-title":"How does warfarin affect the activated coagulation time?","volume":"136","author":"Chang RJ.","year":"1998","journal-title":"Am Heart J."},{"key":"key-20159611030-19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.amjcard.2013.09.043","article-title":"Frequency of radial artery occlusion after transradial access in patients receiving warfarin therapy and undergoing coronary angiography.","volume":"113","author":"Pancholy SB.","year":"2014","journal-title":"Am J Cardiol."},{"key":"key-20159611030-20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4244\/EIJ30V6I4A86","article-title":"How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to \u201cbridge\u201d or not to \u201cbridge\u201d?","volume":"6","author":"Airaksinen KE.","year":"2010","journal-title":"EuroIntervention."},{"key":"key-20159611030-21","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1161\/CIRCULATIONAHA.106.176857","article-title":"ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.","volume":"114","author":"Bonow RW.","year":"2006","journal-title":"Circulation."},{"key":"key-20159611030-22","first-page":"230","article-title":"Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.","volume":"28","author":"Vahanian A.","year":"2007","journal-title":"Eur Heart J."},{"key":"key-20159611030-23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurheartj\/ehi564","article-title":"Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.","volume":"26","author":"Silber S.","year":"2005","journal-title":"Eur Heart J."},{"key":"key-20159611030-24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","article-title":"2007 Focused Update of the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.","volume":"117","author":"King SB 3rd.","year":"2008","journal-title":"Circulation."},{"key":"key-20159611030-25","doi-asserted-by":"publisher","first-page":"9C","DOI":"10.1016\/j.amjcard.2009.06.020","article-title":"Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.","volume":"104","author":"Manoukian SV","year":"2009","journal-title":"Am J Cardiol."},{"key":"key-20159611030-26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.","volume":"376","author":"Wallentin L.","year":"2010","journal-title":"Lancet."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T06:24:45Z","timestamp":1441520685000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/87th_issue\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["20140202-08"],"URL":"https:\/\/doi.org\/10.4244\/eijy14m06_07","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}